This report provides a comprehensive analysis of the global intracranial aneurysm embolization coil market, projecting significant growth through 2032. It examines key product types, materials, and applications, such as neurovascular intervention and various aneurysm morphologies. Market expansion is driven by advancements in minimally invasive therapies, improved cerebrovascular diagnostics, and the rising prevalence of neurointerventional procedures. While facing challenges like high clinical risks and intense competition, the industry is shifting toward integrated, high-performance neurovascular solutions.

Market Overview

The global Intracranial Aneurysm Embolization Coil market is projected to experience significant growth, increasing from US$ 764 million in 2025 to US$ 1484 million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 9.9% from 2026 to 2032.

In 2025, global production of Intracranial Aneurysm Embolization Coils reached approximately 1339 k units. The average gross profit margin for this product is 72%.

Product Definition and Technical Profile

Definition: An Intracranial Aneurysm Embolization Coil is a high-value implantable neurointerventional consumable utilized for the treatment of intracranial aneurysms.

Composition and Components:

• Platinum-tungsten or platinum-based microcoil
• Delivery pusher system
• Detachment mechanism
• Compatible microcatheter

Mechanism of Action: Under digital subtraction angiography guidance, the device is delivered via a minimally invasive femoral or radial arterial approach into the cerebral vasculature. Soft and controllable coils are then deployed into the aneurysm sac to promote thrombus formation and reduce intra-aneurysmal blood flow. This process achieves aneurysm occlusion, thereby lowering the risk of rupture and hemorrhage.

Clinical Role: This product serves as a foundational device in endovascular aneurysm therapy. It is a core consumable frequently used in combination with:

• Stent-assisted coiling
• Balloon-assisted coiling
• Flow diverters
• Intrasaccular embolization systems

Market Dynamics

Growth Drivers and Opportunities

• Improved Diagnosis and Detection: Advancements in imaging screening and the development of stroke centers allow for earlier detection and more systematic management of unruptured and complex aneurysms.
• Expansion of Medical Infrastructure: The growth of neurointerventional centers and the increasing penetration of minimally invasive therapies are driving demand.
• Clinical Advantages over Surgery: Compared to surgical clipping, coil embolization is less invasive, offers faster patient recovery, allows for repeat interventions, and is compatible with various adjunct devices (stents, balloons, flow-diversion) to treat diverse aneurysm morphologies and locations.
• Strategic Platform Value: For device manufacturers, coils serve as a strategic entry point into a broader neurovascular intervention platform. This enables synergistic sales of related products such as microcatheters, guidewires, stents, access systems, and imaging-navigation solutions, enhancing both portfolio value and customer stickiness.
• Expanding Downstream Demand: Demand is shifting from major neurointerventional centers to regional stroke centers, leading tertiary hospitals, and general hospitals equipped with cerebrovascular intervention capabilities.

Key Challenges and Risks

• Clinical and Technical Complexity: Cerebral vessels are small, tortuous, and fragile. Coils must maintain a precise balance of softness, support, visibility, and stability during delivery, framing, filling, and detachment.
• High Clinical Risk: Inappropriate size selection, insufficient packing density, or poor detachment control can lead to serious complications, including aneurysm rupture, thromboembolism, coil migration, recurrence, or the need for retreatment.
• Commercial Pressures: The industry faces price pressure from centralized procurement, the established physician education advantages held by imported brands, and insufficient clinical evidence for certain domestic products.
• Technological Competition: Potential market diversion toward newer flow-diversion and intrasaccular technologies.

Future Market Evolution

Clinicians are increasingly prioritizing coil systems that offer complete specifications, stable framing, reliable detachment, clear radiopacity, and strong microcatheter compatibility. As neurointerventional training improves and domestic brands enter more hospital procurement catalogs, the market is expected to transition from pure price competition toward comprehensive competition based on quality, service, product portfolio, and real-world clinical performance.

Market Segmentation

By Type

• Framing Coil
• Filling Coil
• Finishing Coil
• Hydrogel Coil
• Other

By Coil Material

• Bare Platinum Coil
• Hydrogel-coated Coil
• Fibered Coil
• Bioactive Coil
• Other

By Aneurysm Morphology

• Narrow-neck Aneurysm
• Wide-neck Aneurysm
• Ruptured Aneurysm
• Unruptured Aneurysm
• Other

By Application

• Intracranial Aneurysm Embolization
• Arteriovenous Malformation Embolization
• Parent Vessel Occlusion
• Neurovascular Intervention
• Other

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key companies profiled in this report, selected based on expert input and analysis of product portfolio and market penetration, include:

• Stryker
• Medtronic
• Terumo
• Balt
• MicroPort NeuroTech
• Penumbra
• Johnson & Johnson
• Acandis
• Zylox-Tonbridge

About the Report

Produced by LP Information, Inc. (LPI), the “Intracranial Aneurysm Embolization Coil Industry Forecast” provides a comprehensive analysis of the global landscape. The report reviews total world sales for 2025 and provides detailed projections for 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

Key Analysis Areas:

• Product segmentation, company formation, revenue, and market share.
• Latest developments and M&A activity.
• Leading company strategies, including portfolios, market entry, positions, and geographic footprints.
• Trends, drivers, and affecting factors shaping the global outlook.
• Forecasts by type, application, geography, and market size using a transparent methodology based on hundreds of bottom-up qualitative and quantitative inputs.

Key Questions Addressed

• What is the 10-year outlook for the global Intracranial Aneurysm Embolization Coil market?
• What factors are driving Intracranial Aneurysm Embolization Coil market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Intracranial Aneurysm Embolization Coil market opportunities vary by end market size?
• How does Intracranial Aneurysm Embolization Coil break out by Type and by Application?

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Intracranial Aneurysm Embolization Coil Annual Sales 2021-2032

    • 2.1.2 World Current & Future Analysis for Intracranial Aneurysm Embolization Coil by Geographic Region, 2021, 2025 & 2032

    • 2.1.3 World Current & Future Analysis for Intracranial Aneurysm Embolization Coil by Country/Region, 2021, 2025 & 2032

  • 2.2 Intracranial Aneurysm Embolization Coil Segment by Type

    • 2.2.1 Framing Coil

    • 2.2.2 Filling Coil

    • 2.2.3 Finishing Coil

    • 2.2.4 Hydrogel Coil

    • 2.2.5 Other

    • 2.2.6 Intracranial Aneurysm Embolization Coil Sales by Type

      • 2.2.6.1 Global Intracranial Aneurysm Embolization Coil Sales Market Share by Type (2021-2026)
      • 2.2.6.2 Global Intracranial Aneurysm Embolization Coil Revenue and Market Share by Type (2021-2026)
      • 2.2.6.3 Global Intracranial Aneurysm Embolization Coil Sale Price by Type (2021-2026)

  • 2.3 Intracranial Aneurysm Embolization Coil Segment by Coil Material

    • 2.3.1 Bare Platinum Coil

    • 2.3.2 Hydrogel-coated Coil

    • 2.3.3 Fibered Coil

    • 2.3.4 Bioactive Coil

    • 2.3.5 Other

    • 2.3.6 Intracranial Aneurysm Embolization Coil Sales by Coil Material

      • 2.3.6.1 Global Intracranial Aneurysm Embolization Coil Sales Market Share by Coil Material (2021-2026)
      • 2.3.6.2 Global Intracranial Aneurysm Embolization Coil Revenue and Market Share by Coil Material (2021-2026)
      • 2.3.6.3 Global Intracranial Aneurysm Embolization Coil Sale Price by Coil Material (2021-2026)

  • 2.4 Intracranial Aneurysm Embolization Coil Segment by Aneurysm Morphology

    • 2.4.1 Narrow-neck Aneurysm

    • 2.4.2 Wide-neck Aneurysm

    • 2.4.3 Ruptured Aneurysm

    • 2.4.4 Unruptured Aneurysm

    • 2.4.5 Other

    • 2.4.6 Intracranial Aneurysm Embolization Coil Sales by Aneurysm Morphology

      • 2.4.6.1 Global Intracranial Aneurysm Embolization Coil Sales Market Share by Aneurysm Morphology (2021-2026)
      • 2.4.6.2 Global Intracranial Aneurysm Embolization Coil Revenue and Market Share by Aneurysm Morphology (2021-2026)
      • 2.4.6.3 Global Intracranial Aneurysm Embolization Coil Sale Price by Aneurysm Morphology (2021-2026)

  • 2.5 Intracranial Aneurysm Embolization Coil Segment by Application

    • 2.5.1 Intracranial Aneurysm Embolization

    • 2.5.2 Arteriovenous Malformation Embolization

    • 2.5.3 Parent Vessel Occlusion

    • 2.5.4 Neurovascular Intervention

    • 2.5.5 Other

    • 2.5.6 Intracranial Aneurysm Embolization Coil Sales by Application

      • 2.5.6.1 Global Intracranial Aneurysm Embolization Coil Sale Market Share by Application (2021-2026)
      • 2.5.6.2 Global Intracranial Aneurysm Embolization Coil Revenue and Market Share by Application (2021-2026)
      • 2.5.6.3 Global Intracranial Aneurysm Embolization Coil Sale Price by Application (2021-2026)

• 3 Global by Company

  • 3.1 Global Intracranial Aneurysm Embolization Coil Breakdown Data by Company

    • 3.1.1 Global Intracranial Aneurysm Embolization Coil Annual Sales by Company (2021-2026)

    • 3.1.2 Global Intracranial Aneurysm Embolization Coil Sales Market Share by Company (2021-2026)

  • 3.2 Global Intracranial Aneurysm Embolization Coil Annual Revenue by Company (2021-2026)

    • 3.2.1 Global Intracranial Aneurysm Embolization Coil Revenue by Company (2021-2026)

    • 3.2.2 Global Intracranial Aneurysm Embolization Coil Revenue Market Share by Company (2021-2026)

  • 3.3 Global Intracranial Aneurysm Embolization Coil Sale Price by Company

  • 3.4 Key Manufacturers Intracranial Aneurysm Embolization Coil Producing Area Distribution, Sales Area, Product Type

    • 3.4.1 Key Manufacturers Intracranial Aneurysm Embolization Coil Product Location Distribution

    • 3.4.2 Players Intracranial Aneurysm Embolization Coil Products Offered

  • 3.5 Market Concentration Rate Analysis

    • 3.5.1 Competition Landscape Analysis

    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.6 New Products and Potential Entrants

  • 3.7 Market M&A Activity & Strategy

• 4 World Historic Review for Intracranial Aneurysm Embolization Coil by Geographic Region

  • 4.1 World Historic Intracranial Aneurysm Embolization Coil Market Size by Geographic Region (2021-2026)

    • 4.1.1 Global Intracranial Aneurysm Embolization Coil Annual Sales by Geographic Region (2021-2026)

    • 4.1.2 Global Intracranial Aneurysm Embolization Coil Annual Revenue by Geographic Region (2021-2026)

  • 4.2 World Historic Intracranial Aneurysm Embolization Coil Market Size by Country/Region (2021-2026)

    • 4.2.1 Global Intracranial Aneurysm Embolization Coil Annual Sales by Country/Region (2021-2026)

    • 4.2.2 Global Intracranial Aneurysm Embolization Coil Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Intracranial Aneurysm Embolization Coil Sales Growth

  • 4.4 APAC Intracranial Aneurysm Embolization Coil Sales Growth

  • 4.5 Europe Intracranial Aneurysm Embolization Coil Sales Growth

  • 4.6 Middle East & Africa Intracranial Aneurysm Embolization Coil Sales Growth

• 5 Americas

  • 5.1 Americas Intracranial Aneurysm Embolization Coil Sales by Country

    • 5.1.1 Americas Intracranial Aneurysm Embolization Coil Sales by Country (2021-2026)

    • 5.1.2 Americas Intracranial Aneurysm Embolization Coil Revenue by Country (2021-2026)

  • 5.2 Americas Intracranial Aneurysm Embolization Coil Sales by Type (2021-2026)

  • 5.3 Americas Intracranial Aneurysm Embolization Coil Sales by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Intracranial Aneurysm Embolization Coil Sales by Region

    • 6.1.1 APAC Intracranial Aneurysm Embolization Coil Sales by Region (2021-2026)

    • 6.1.2 APAC Intracranial Aneurysm Embolization Coil Revenue by Region (2021-2026)

  • 6.2 APAC Intracranial Aneurysm Embolization Coil Sales by Type (2021-2026)

  • 6.3 APAC Intracranial Aneurysm Embolization Coil Sales by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

  • 6.10 China Taiwan

• 7 Europe

  • 7.1 Europe Intracranial Aneurysm Embolization Coil by Country

    • 7.1.1 Europe Intracranial Aneurysm Embolization Coil Sales by Country (2021-2026)

    • 7.1.2 Europe Intracranial Aneurysm Embolization Coil Revenue by Country (2021-2026)

  • 7.2 Europe Intracranial Aneurysm Embolization Coil Sales by Type (2021-2026)

  • 7.3 Europe Intracranial Aneurysm Embolization Coil Sales by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Intracranial Aneurysm Embolization Coil by Country

    • 8.1.1 Middle East & Africa Intracranial Aneurysm Embolization Coil Sales by Country (2021-2026)

    • 8.1.2 Middle East & Africa Intracranial Aneurysm Embolization Coil Revenue by Country (2021-2026)

  • 8.2 Middle East & Africa Intracranial Aneurysm Embolization Coil Sales by Type (2021-2026)

  • 8.3 Middle East & Africa Intracranial Aneurysm Embolization Coil Sales by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers

  • 10.2 Manufacturing Cost Structure Analysis of Intracranial Aneurysm Embolization Coil

  • 10.3 Manufacturing Process Analysis of Intracranial Aneurysm Embolization Coil

  • 10.4 Industry Chain Structure of Intracranial Aneurysm Embolization Coil

• 11 Marketing, Distributors and Customer

  • 11.1 Sales Channel

    • 11.1.1 Direct Channels

    • 11.1.2 Indirect Channels

  • 11.2 Intracranial Aneurysm Embolization Coil Distributors

  • 11.3 Intracranial Aneurysm Embolization Coil Customer

• 12 World Forecast Review for Intracranial Aneurysm Embolization Coil by Geographic Region

  • 12.1 Global Intracranial Aneurysm Embolization Coil Market Size Forecast by Region

    • 12.1.1 Global Intracranial Aneurysm Embolization Coil Forecast by Region (2027-2032)

    • 12.1.2 Global Intracranial Aneurysm Embolization Coil Annual Revenue Forecast by Region (2027-2032)

  • 12.2 Americas Forecast by Country (2027-2032)

  • 12.3 APAC Forecast by Region (2027-2032)

  • 12.4 Europe Forecast by Country (2027-2032)

  • 12.5 Middle East & Africa Forecast by Country (2027-2032)

  • 12.6 Global Intracranial Aneurysm Embolization Coil Forecast by Type (2027-2032)

  • 12.7 Global Intracranial Aneurysm Embolization Coil Forecast by Application (2027-2032)

• 13 Key Players Analysis

  • 13.1 Stryker

    • 13.1.1 Stryker Company Information

    • 13.1.2 Stryker Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.1.3 Stryker Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.1.4 Stryker Main Business Overview

    • 13.1.5 Stryker Latest Developments

  • 13.2 Medtronic

    • 13.2.1 Medtronic Company Information

    • 13.2.2 Medtronic Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.2.3 Medtronic Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.2.4 Medtronic Main Business Overview

    • 13.2.5 Medtronic Latest Developments

  • 13.3 Terumo

    • 13.3.1 Terumo Company Information

    • 13.3.2 Terumo Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.3.3 Terumo Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.3.4 Terumo Main Business Overview

    • 13.3.5 Terumo Latest Developments

  • 13.4 Balt

    • 13.4.1 Balt Company Information

    • 13.4.2 Balt Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.4.3 Balt Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.4.4 Balt Main Business Overview

    • 13.4.5 Balt Latest Developments

  • 13.5 MicroPort NeuroTech

    • 13.5.1 MicroPort NeuroTech Company Information

    • 13.5.2 MicroPort NeuroTech Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.5.3 MicroPort NeuroTech Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.5.4 MicroPort NeuroTech Main Business Overview

    • 13.5.5 MicroPort NeuroTech Latest Developments

  • 13.6 Penumbra

    • 13.6.1 Penumbra Company Information

    • 13.6.2 Penumbra Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.6.3 Penumbra Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.6.4 Penumbra Main Business Overview

    • 13.6.5 Penumbra Latest Developments

  • 13.7 Johnson & Johnson

    • 13.7.1 Johnson & Johnson Company Information

    • 13.7.2 Johnson & Johnson Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.7.3 Johnson & Johnson Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.7.4 Johnson & Johnson Main Business Overview

    • 13.7.5 Johnson & Johnson Latest Developments

  • 13.8 Acandis

    • 13.8.1 Acandis Company Information

    • 13.8.2 Acandis Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.8.3 Acandis Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.8.4 Acandis Main Business Overview

    • 13.8.5 Acandis Latest Developments

  • 13.9 Zylox-Tonbridge

    • 13.9.1 Zylox-Tonbridge Company Information

    • 13.9.2 Zylox-Tonbridge Intracranial Aneurysm Embolization Coil Product Portfolios and Specifications

    • 13.9.3 Zylox-Tonbridge Intracranial Aneurysm Embolization Coil Sales, Revenue, Price and Gross Margin (2021-2026)

    • 13.9.4 Zylox-Tonbridge Main Business Overview

    • 13.9.5 Zylox-Tonbridge Latest Developments

• 14 Research Findings and Conclusion